indazoles has been researched along with natriuretic peptide, brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, K; Han, F; Kamata, A; Lu, YM; Qin, ZH; Shioda, N; Shirasaki, Y | 1 |
| Angeli, FS; Judge, DP; Lakdawala, NK; Lee, PA; Li, H; MacRae, CA; Mestroni, L; Oliver, C; Taylor, MRG | 1 |
2 other study(ies) available for indazoles and natriuretic peptide, brain
| Article | Year |
|---|---|
DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Benzylamines; Butadienes; Calcimycin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cell Proliferation; Cell Size; Cells, Cultured; DNA Replication; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Indazoles; Ionophores; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Wistar; RNA, Messenger; Sulfonamides; Time Factors; Transfection | 2009 |
Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Ethylenediamines; Female; Humans; Indazoles; Lamin Type A; Male; Middle Aged; Mitogen-Activated Protein Kinase 14; Natriuretic Peptide, Brain; Randomized Controlled Trials as Topic | 2022 |